By July 8, Salesforce’s (NYSE: CRM) 2026 market and business performance appears to have started getting reflected in the CRM stock price targets and ratings.
Specifically, Jackson Ader, a KeyBanc analyst, revealed in a Wednesday note that he has downgraded the equity from ‘Overweight’ – ‘Buy’ – to ‘Sector Weight’ – ‘Hold.’
The Wall Street expert explained that, while his institution’s opinion that the ‘Death of SaaS’ narrative is overstated due to Salesforce’s position and incumbency advantage remains, it appears that the road to greater success will prove longer than previously expected.
Indeed, while still estimating that Agentforce can succeed, Ader offers some rather scathing remarks that finding evidence for the company’s narrative about artificial intelligence (AI)-related growth has proven difficult.
Furthermore, the analyst concluded that the new and novel product ‘just is not there’ yet, and that many major customers appear intent on temporarily deprioritizing Salesforce in their budgets before reprioritizing later down the line.
Still, despite the overall tone of the analysis, KeyBanc’s Jackson Ader emphasized the company’s long-term conviction in its assessment of the ‘Death of SaaS’ narrative as it relates to CRM stock, though not as steadfast as before.
Analysts predict Salesforce stock price in the next 12 months
Elsewhere, the July 8 note stands in stark contrast with the wider view held by Wall Street. Not only have the majority of assessments published in the last 30 days been bullish – and none bearish – but Salesforce stock is overall considered a ‘Moderate Buy’ by institutional experts.
Additionally, Wall Street expects CRM shares to rally 46.60% to $244.21 in the next 12 months, per the data Finbold retrieved from TipRanks on July 9.
2026 CRM stock price chart
Lastly, the overall analyst attitude stands in stark contrast with Salesforce stock’s market performance. At the latest close on July 8, CRM shares were changing hands at $166.58, meaning they are down 34.32% year-to-date (YTD).
Short-term performance is hardly more positive since, barring a brief spike at the start of June, the equity’s downtrend has continued in recent weeks and extended on the morning of July 9 with a 3.73% pre-market plunge to $160.37.
Featured image via Shutterstock
